RTTR stock forecast
Our latest prediction for Ritter Pharmaceuticals, Inc.'s stock price was made on the Oct. 3, 2017 when the stock price was at 0.36$.
In the short term (2weeks), RTTR's stock price should outperform the market by 7.79%. During that period the price should oscillate between -11.10% and +26.36%.
In the medium term (3months), RTTR's stock price should outperform the market by 13.82%. During that period the price should oscillate between -21.60% and +77.85%.Get email alerts
About Ritter Pharmaceuticals, Inc.
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.80$ per share.
The book value per share is 1.93$
Three months stock forecastOct. 3, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|